Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Epiroc B | EPIB | Mar 18, 2024 | 182.00 | -1.52 |
Episurf Medical B | EPISB | Mar 18, 2024 | 0.78 | -3.46 |
EQL Pharma | EQL | Mar 18, 2024 | 38.70 | -0.77 |
EQT | EQT | Mar 18, 2024 | 334.00 | -2.17 |
Ericsson A | ERICA | Mar 18, 2024 | 56.30 | -8.31 |
Ericsson B | ERICB | Mar 18, 2024 | 56.14 | -5.41 |
ES Energy Save Holding | ESGRB | Mar 18, 2024 | 35.00 | -4.11 |
Essity A | ESSITYA | Mar 18, 2024 | 248.50 | -0.20 |
Essity B | ESSITYB | Mar 18, 2024 | 247.80 | -0.92 |
Euroafrica Digital Ventures | EURA | Mar 18, 2024 | 0.05 | -4.33 |
Eurobattery Minerals | BAT | Mar 18, 2024 | 0.37 | -1.58 |
Eurocine Vaccines | EUCI | Mar 18, 2024 | 0.02 | +14.29 |
European Institute of Science B | EURIB | Mar 18, 2024 | 4.41 | -0.23 |
Everysport Group AB | EVERY | Mar 18, 2024 | 18.80 | +1.62 |
Evolution | EVO | Mar 18, 2024 | 1 365.60 | -0.35 |
Ework Group AB. | EWRK | Mar 18, 2024 | 135.60 | +0.44 |
Exalt | EXALT | Mar 18, 2024 | 0.46 | +3.11 |
ExpreS2ion Biotech Holding | EXPRS2 | Mar 18, 2024 | 2.44 | +1.03 |
Exsitec | EXS | Mar 18, 2024 | 161.00 | -2.42 |
Eyeonid Group | EOID | Mar 18, 2024 | 5.48 | +2.62 |
Fabege | FABG | Mar 18, 2024 | 90.86 | -1.15 |
Fable Media Group AB | FABLE | Mar 18, 2024 | 4.81 | -4.18 |
Fagerhult Group AB | FAG | Mar 18, 2024 | 68.30 | +3.02 |
Fantasma Games | FAGA | Mar 18, 2024 | 44.00 | -3.08 |
Fasadgruppen | FG | Mar 18, 2024 | 62.90 | -0.63 |
Fastator | FASTAT | Mar 18, 2024 | 1.18 | -5.75 |
Fastout Int | FOUT | Mar 18, 2024 | 0.09 | -5.26 |
Fastpartner A | FPARA | Mar 18, 2024 | 70.10 | -1.27 |
Fastpartner D | FPARD | Mar 18, 2024 | 65.00 | 0.00 |
Fenix Outdoor B | FOIB | Mar 18, 2024 | 637.00 | -0.16 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.